Jason P. Rhodes
Chief Financial Officer, Epizyme, Inc.
Companies
- Dyne Therapeutics, Inc.Board member Sep 16, 2020 to now1
- Generation Bio Co.Board member Jun 11, 2020 to now2
- Replimune Group, Inc.Board member Jul 19, 2018 to Apr 5, 20223
- Disc Medicine, Inc.Board member Feb 11, 2021 to Oct 6, 20214
- Epizyme, Inc.President Jul 3, 2013 to Sep 24, 20145
- Epizyme, Inc.Chief financial officer May 30, 2013 to Sep 24, 20146
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Dyne Therapeutics, Inc. DYN2,962 shares7$44.4K at $14.99Aug 17, 2026
- Generation Bio Co.0 shares8Feb 9, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 14, 2026Sold 322,465 shares at $25.00 of Dyne Therapeutics, Inc.7
- Aug 14, 2026Sold 478,377 shares at $25.00 of Dyne Therapeutics, Inc.7
- Aug 14, 2026Sold 1,359,674 shares at $25.00 of Dyne Therapeutics, Inc.7
- Aug 13, 2026Sold 63,643 shares at $26.20 of Dyne Therapeutics, Inc.7
- Aug 13, 2026Sold 94,415 shares at $26.20 of Dyne Therapeutics, Inc.7
- Aug 13, 2026Sold 268,354 shares at $26.20 of Dyne Therapeutics, Inc.7
- Jul 7, 2026Sold 5,000 shares at $23.61 of Dyne Therapeutics, Inc.9
- Jul 7, 2026Sold 11,665 shares at $23.62 of Dyne Therapeutics, Inc.9
- Jul 7, 2026Sold 49,193 shares at $23.17 of Dyne Therapeutics, Inc.9
- Jul 7, 2026Sold 14,844 shares at $23.62 of Dyne Therapeutics, Inc.9
- Jul 7, 2026Sold 62,543 shares at $23.17 of Dyne Therapeutics, Inc.9
- Jul 7, 2026Sold 29,587 shares at $23.62 of Dyne Therapeutics, Inc.9
- Jul 7, 2026Sold 124,379 shares at $23.17 of Dyne Therapeutics, Inc.9
- Jul 6, 2026Sold 100,019 shares at $22.79 of Dyne Therapeutics, Inc.9
- Jul 6, 2026Sold 127,182 shares at $22.79 of Dyne Therapeutics, Inc.9
- Jul 6, 2026Sold 253,039 shares at $22.79 of Dyne Therapeutics, Inc.9
- Jun 29, 2026Sold 40,702 shares at $21.14 of Dyne Therapeutics, Inc.10
- Jun 29, 2026Sold 51,756 shares at $21.14 of Dyne Therapeutics, Inc.10
- Jun 29, 2026Sold 102,969 shares at $21.14 of Dyne Therapeutics, Inc.10
- Jun 26, 2026Sold 64,411 shares at $21.28 of Dyne Therapeutics, Inc.10
- Jun 26, 2026Sold 81,903 shares at $21.28 of Dyne Therapeutics, Inc.10
- Jun 26, 2026Sold 162,954 shares at $21.28 of Dyne Therapeutics, Inc.10
- Jun 25, 2026Sold 5,019 shares at $21.10 of Dyne Therapeutics, Inc.11
- Jun 25, 2026Sold 6,382 shares at $21.10 of Dyne Therapeutics, Inc.11
- Jun 25, 2026Sold 12,699 shares at $21.10 of Dyne Therapeutics, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARGeneration Bio Co., Board member
- 3SEC EDGARReplimune Group, Inc., Board member
- 4SEC EDGARDisc Medicine, Inc., Board member
- 5SEC EDGAREpizyme, Inc., President
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jul 8, 2026
- 10SEC EDGARForm 4 filed Jun 30, 2026
- 11SEC EDGARForm 4 filed Jun 26, 2026